HUM vs ONCO · P/E 39, rev $129.66B vs P/E 0.0, rev $2.5M
Humana Inc (HUM) versus Onconetix Inc (ONCO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Onconetix Inc (ONCO) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported ONCO revenue for 2024-12-31 was $2.5M. Net income was -$58.7M. Revenue was up 4217.3% from 2023-12-31 to 2024-12-31. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
Not investment advice. Open the HUM and ONCO stock pages for the full models.
Not investment advice.